HSBC Continental Europe
HSBC Continental Europe: Post Stabilisation Notice
HSBC Continental Europe: Post Stabilisation Notice
PARIS, Feb. 13, 2025 (GLOBE NEWSWIRE) --
Assicurazioni Generali S.p.A.
Post Stabilisation Notice
HSBC (contact: syndexecution@noexternalmail.hsbc.com) hereby gives notice that no stabilisation was undertaken by the Stabilisation Manager(s) named below in relation to the offer of the following securities.
| Issuer: | Assicurazioni Generali S.p.A. |
| Guarantor (if any): | na |
| Aggregate nominal amount: | EUR 500,000,000 |
| Description: | 4.083% due 16th July 2035 |
| Offer price: | 100 |
| Stabilising Manager: | HSBC Continental Europe |
This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Robex Resources Inc.21.12.2025 23:28:03 CET | Press release
Robex Pours First Gold at Kiniéro on Schedule and Budget
ALK Abello19.12.2025 22:46:46 CET | Press release
Major shareholder announcement
ALK Abello19.12.2025 22:46:46 CET | Pressemeddelelse
Storaktionærmeddelelse
Zealand Pharma19.12.2025 22:00:00 CET | Press release
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Boehringer Ingelheim Limited19.12.2025 21:10:00 CET | Press release
U.S. FDA approves JASCAYD® (nerandomilast) tablets for the treatment of progressive pulmonary fibrosis in adults
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom